Evidence map›Paper›PMID 33247008›Full record

ArticleBMJ open2020

3D-printed brace in the treatment of adolescent idiopathic scoliosis: a study protocol of a prospective randomised controlled trial.

Youyu Zhang, Junyang Liang, Nanfang Xu, Lin Zeng, Chaojun Du, Yaoxu Du, Yan Zeng, Miao Yu, Zhongjun Liu

Open access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in BMJ open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Trial
  2. Article
  3. Global evolution of adolescent idiopathic scoliosis research (1990-2025): a bibliometric and visualization analysis.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2026
    Article
  4. Review
  5. Article
  6. Review
  7. Adolescent Idiopathic Scoliosis: Advances in Diagnosis and Management.Current reviews in musculoskeletal medicine · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Youyu Zhang *Department of Orthopedics, Peking University Third Hospital, Beijing, China.ORCID 0000-0001-5606-620X
Junyang Liang *Department of Spinal Surgery, Weihai Wei People's Hospital, Weihai, China.
Nanfang XuDepartment of Orthopedics, Peking University Third Hospital, Beijing, China xunanfang@foxmail.com.ORCID 0000-0001-5888-293X
Lin ZengResearch Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, China.ORCID 0000-0001-8707-5854
Chaojun DuDepartment of Orthotics and Prosthetics, Peking University Third Hospital, Beijing, China.
Yaoxu DuDepartment of Orthotics and Prosthetics, Peking University Third Hospital, Beijing, China.
Yan ZengDepartment of Orthopedics, Peking University Third Hospital, Beijing, China.
Miao YuDepartment of Orthopedics, Peking University Third Hospital, Beijing, China.
Zhongjun LiuDepartment of Orthopedics, Peking University Third Hospital, Beijing, China.
Peking University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAdolescent idiopathic scoliosis (AIS) is a three-dimensional deformity of the spine. Brace treatment is effective for eligible patients with AIS and the effectiveness is significantly correlated with the average brace-wear time per day. Three-dimensional (3D) printing technology is a recent advancement that offers unique opportunities for biomedical applications, and customisation of scoliosis braces might lead to greater patient satisfaction and improved compliance. We present here the design of a randomised controlled trial on the clinical effectiveness of 3D-printed braces versus thoracolumbosacral orthoses (TLSO) for patients with AIS. METHODS AND ANALYSIS: Patients with AIS (age 10-16 years) with Risser sign 0-II, Cobb angle of main curve of 20°-40°, premenarchal or no more than 1-year postmenarchal (for women), and no history of treatment are eligible, unless they are unable to tolerate the treatment or refuse participation. A total of 88 patients will be randomised into either the 3D group or TLSO group on a 1:1 basis. Participants in the 3D group will choose between a 3D-printed brace and TLSO, according to the Zelen's design of the trial. Primary outcome measures will include the average brace-wear time per day, health-related quality of life and Cobb angle progression of the primary curve. Secondary outcome measures will include immediate in-brace correction of Cobb angle of the primary curve, rate of conversion to surgery and incidence of any adverse events. This study is designed as a single-centre, two-arm, superiority and open-label randomised controlled trial. The sample size is calculated with reference to the preliminary study and based on the sample size calculation formula. ETHICS AND DISSEMINATION: This study was approved by the Peking University Third Hospital Medicine Science Research Ethics Committee (No: 2019-017-02). Results of the trial will be submitted for publication in a peer-reviewed journal and as conference presentations. TRIAL REGISTRATION NUMBER: ChiCTR1900027379, pre-results.

Indexed as

BracesScoliosisAdolescentChildEquivalence Trials as TopicFemaleHumansPrinting, Three-DimensionalProspective StudiesQuality of LifeRandomized Controlled Trials as TopicTreatment Outcomeclinical trialspaediatric orthopaedicsscoliosis

Identifiers

PMID33247008
PMCPMC7703428
OpenAlexW3107487150

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.